The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Agios Pharmaceuticals, Inc(NASDAQ:AGIO) 
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refracto...
Website: http://www.agios.com
Founded: 2008
Full Time Employees: 536
Sector: Healthcare
Industry: Biotechnology
Agios Pharmaceuticals Days Payable Outstanding ttm (DPO)
Agios Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Agios Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Agios Pharmaceuticals Op Cashflow Per Share ttm
Agios Pharmaceuticals Free Cashflow Per Share ttm
Agios Pharmaceuticals Cash Per Share ttm
Agios Pharmaceuticals P/S ratio ttm
Agios Pharmaceuticals (GAAP) P/E ratio ttm
Agios Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.